West Enclave Merger Corp

West Enclave Merger Corp (WENC) Stock Analysis

$9.985

-0.005 (-0.05%)At close

Loading chart…
High
10.000
Open
10.000
VWAP
9.99
Vol
2.65K
Mkt Cap
Low
9.985
Amount
26.44K
EV/EBITDA, TTM
0.00

West Enclave Merger Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The Company has conducted no operations and has generated no revenues.

AI analysis of West Enclave Merger Corp (WENC)

hold

West Enclave Merger Corp. (WENC) is not a strong buy at this moment. The current price is $9.98, and the RSI is at 48.34, indicating a neutral momentum. The company has a high debt-to-equity ratio of 20.32%, which poses a risk, especially given its negative net income of $40,398 in Q1 2026. While the stock has shown a slight increase of 1.27% year-to-date, the lack of positive financial performance and high valuation metrics suggest caution.

Valuation Metrics

The current forward P/E ratio for West Enclave Merger Corp (WENC) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

WENC FAQ — answered by Alphio AI

West Enclave Merger Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The Company has conducted no operations and has generated no revenues. It operates in the Financials sector.

West Enclave Merger Corp. (WENC) is not a strong buy at this moment. The current price is $9.98, and the RSI is at 48.34, indicating a neutral momentum. The company has a high debt-to-equity ratio of 20.32%, which poses a risk, especially given its negative net income of $40,398 in Q1 2026. While the stock has shown a slight increase of 1.27% year-to-date, the lack of positive financial performance and high valuation metrics suggest caution.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started